FDA Approves Proteus Digital Health’s E-pills for Dose Monitoring

FDA Approves Proteus Digital Health’s E-pills for Dose Monitoring 

An "ingestible sensor" doesn’t sound like the tastiest of snacks, but soon it might be just what the doctor ordered. A tiny microchip which activates upon contact with stomach acid has recently been approved by the FDA. When the sensor is swallowed, an external patch picks up its signal and sends a message. The technology could improve compliance as correct timing and dose are important for many drugs, and lax schedules can be responsible for treatment failures or even the development of drug-resistant bugs. Although the pills have only been used in trials, one pharmaceutical company has purchased a license to the technology. If you don’t like the thought of a belly full of microchips, no need to worry — the harmless sensors pass naturally after completing their mission.